Wordt geladen...
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
Chromosomal rearrangements involving neurotrophic tyrosine kinase 1 (NTRK1) occur in a subset of non-small cell lung cancers (NSCLCs) and other solid tumor malignancies, leading to expression of an oncogenic TrkA fusion protein. Entrectinib (RXDX-101) is an orally available tyrosine kinase inhibitor...
Bewaard in:
Gepubliceerd in: | J Thorac Oncol |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Lippincott Williams & Wilkins
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4643748/ https://ncbi.nlm.nih.gov/pubmed/26565381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.JTO.0000473485.38553.f0 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|